it's just not the fact that we have progressed our battery technology and performance, increased our battery counterparties to 26 and look to add common list approval to our CE mark approval and have progressed our covid/flu multiplex and sepsis tests this year.
it's how we have attracted quality appointments to our team this year.
Ewen Crouch, read parts of bluescope and Corporate Travel's annual reports to see the experience and negotiation ability he adds
https://www.listcorp.com/asx/ctd/co...al-report-2748260.html?ref=trending_news_home
https://www.listcorp.com/asx/bsl/bl...ws/annual-report-to-shareholders-2595457.html
David Radford, still 5 weeks before he starts with us. has a very strong history of adding shareholder wealth to companies he's joined.
Conor Marley, "One of 3 IMO Lead's for the +/- $100B Chevron Texaco Merger. "
https://www.linkedin.com/in/conormarley/
Kalani Periyapperuma, Project Lead - Silicon anode development, was the project manager for Future Battery Industries CRC Future Electrolyte Systems project and after we joined the project in March has now joined our battery team.
https://www.linkedin.com/in/kalani-periyapperuma/
Christian Page 3rd member of our Battery advisory board. also currently head of Trinseo Battery Business
https://www.linkedin.com/in/christian-page-8725534/
what we have done in 2022 has been able to attract top quality people to join our team. we have hired 2 clinical trial specialists to our team, hired AKRN to run out European trial, expanded our distributors in Europe as well our our battery collaborators to 26.
I'm never sure of sp movement in the short term. but IMO when the fundamentals keep improving the sp will follow accordingly. GLTAH. DYOR. ETC ETC
2022 the year of ADO.......
- Forums
- ASX - By Stock
- ADO
- Shooting the breeze on ADO
Shooting the breeze on ADO, page-1531
-
-
- There are more pages in this discussion • 4,144 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
|
|||||
Last
2.2¢ |
Change
0.001(4.76%) |
Mkt cap ! $54.30M |
Open | High | Low | Value | Volume |
2.1¢ | 2.2¢ | 2.1¢ | $12.91K | 587.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 371473 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 289608 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 371473 | 0.021 |
13 | 2204550 | 0.020 |
8 | 2890767 | 0.019 |
10 | 1652665 | 0.018 |
3 | 94160 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 289608 | 2 |
0.023 | 864053 | 6 |
0.024 | 1306228 | 3 |
0.025 | 214144 | 4 |
0.027 | 680612 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online